Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Stevanato Group S.p.A. (NYSE:STVN - Get Free Report) have earned a consensus rating of "Moderate Buy" from the seven analysts that are covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company.

Several brokerages recently issued reports on STVN. Bank of America upped their price objective on shares of Stevanato Group from $24.00 to $26.00 and gave the company a "buy" rating in a research note on Friday, December 13th. Morgan Stanley reissued an "equal weight" rating and set a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. UBS Group lowered their price objective on Stevanato Group from $24.00 to $23.50 and set a "neutral" rating for the company in a research report on Friday, March 7th. Wolfe Research initiated coverage on Stevanato Group in a research report on Friday, December 13th. They set an "outperform" rating and a $28.00 target price on the stock. Finally, William Blair reissued an "outperform" rating on shares of Stevanato Group in a research note on Friday, March 7th.

Institutional Investors Weigh In On Stevanato Group

Several institutional investors and hedge funds have recently added to or reduced their stakes in STVN. Van Berkom & Associates Inc. acquired a new position in shares of Stevanato Group in the 4th quarter valued at about $39,000. Johnson Financial Group Inc. acquired a new position in Stevanato Group during the fourth quarter valued at approximately $41,000. Wells Fargo & Company MN lifted its position in Stevanato Group by 680.3% during the fourth quarter. Wells Fargo & Company MN now owns 3,246 shares of the company's stock valued at $71,000 after buying an additional 2,830 shares in the last quarter. PNC Financial Services Group Inc. grew its stake in Stevanato Group by 1,457.6% during the fourth quarter. PNC Financial Services Group Inc. now owns 5,654 shares of the company's stock worth $123,000 after buying an additional 5,291 shares during the period. Finally, Tower Research Capital LLC TRC increased its position in shares of Stevanato Group by 202.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company's stock worth $162,000 after acquiring an additional 4,965 shares in the last quarter.

Stevanato Group Price Performance

NYSE:STVN traded down €0.11 ($0.12) during trading hours on Friday, reaching €21.00 ($22.58). 412,051 shares of the company traded hands, compared to its average volume of 348,474. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.81 and a quick ratio of 1.21. The firm's 50-day moving average is €21.03 and its 200-day moving average is €20.59. The stock has a market cap of $6.36 billion, a P/E ratio of 44.68, a P/E/G ratio of 7.18 and a beta of 0.60. Stevanato Group has a 1-year low of €16.56 ($17.81) and a 1-year high of €33.49 ($36.01).

Stevanato Group (NYSE:STVN - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The company reported €0.20 ($0.22) EPS for the quarter, hitting analysts' consensus estimates of €0.20 ($0.22). Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm had revenue of €352.68 million during the quarter, compared to analysts' expectations of €346.26 million. Equities research analysts expect that Stevanato Group will post 0.5 earnings per share for the current fiscal year.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.